Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study

about

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study

Item

http://www.wikidata.org/entity/Q56518823

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Recombinant human soluble thro ...... lopathy: a retrospective study

@en

Recombinant human soluble thro ...... lopathy: a retrospective study

@nl

type

Item

label

Recombinant human soluble thro ...... lopathy: a retrospective study

@en

Recombinant human soluble thro ...... lopathy: a retrospective study

@nl

prefLabel

Recombinant human soluble thro ...... lopathy: a retrospective study

@en

Recombinant human soluble thro ...... lopathy: a retrospective study

@nl

P1476

Recombinant human soluble thro ...... lopathy: a retrospective study

@en

P2093

Katsuhiko Matsuura

http://www.w3.org/2001/XMLSchema#string

Takahiro Kato

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

The epidemiology of sepsis in the United States from 1979 through 2000

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Thrombosis as an intravascular effector of innate immunity.

Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation.

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

P2888

s12959-018-0172-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12959-018-0172-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104340033

http://www.w3.org/2001/XMLSchema#string

P698

30158838

http://www.w3.org/2001/XMLSchema#string

P921

hematology

P932

6107946

http://www.w3.org/2001/XMLSchema#string